These innate pathways contribute significantly to the development of inflammatory disorders [16], kidney disease [15], and metabolic diseases [17], and inflammasome components are upregulated in dysferlin-deficient muscular dystrophy [18]. The gene discussed is DYSF; the disease is muscular dystrophy.